Chimeric Molecules Facilitate the Degradation of Androgen Receptors and Repress the Growth of LNCaP Cells

Asian Journal of Andrology - India
doi 10.1038/aja.2008.26
Full Text
Abstract

Available in full text

Categories
MedicineUrology
Date
Authors
Publisher

Medknow

Related search

Androgen Upregulates the Palmitoylation of eIF3L in Human Prostate LNCaP Cells

OncoTargets and Therapy
OncologyPharmacology
2019English

Tea Polyphenols Down-Regulate the Expression of the Androgen Receptor in LNCaP Prostate Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Regulation of Androgen Receptor by Androgen and Epidermal Growth Factor in a Human Prostatic Cancer Cell Line, LNCaP.

Endocrinologia Japonica
1992English

Dutasteride and Metformin Reduce the Growth of LNCaP Cells and Alter the SREBP-1 Pathway

The Open Prostate Cancer Journal
2013English

Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence

Cancer Prevention Research
MedicineCancer ResearchOncology
2010English

In LNCaP Cells Enhanced Expression of the Androgen Receptor Compensates for BCL-2 Suppression by Antisense Oligonucleotides

Therapeutic Advances in Urology
Urology
2011English

The Other Face of Chimeric Antigen Receptors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Enhanced Sensitivity to Androgen Withdrawal Due to Overexpression of Interleukin-6 in Androgen-Dependent Human Prostate Cancer LNCaP Cells

British Journal of Cancer
Cancer ResearchOncology
2009English

Androgen Receptor Activity Is Affected by Both Nuclear Matrix Localization and the Phosphorylation Status of the Heterogeneous Nuclear Ribonucleoprotein K in Anti-Androgen-Treated LNCaP Cells

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy